Skip to content

Enterprise value at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.42B+18.1%
Opko Health logo
Opko HealthOPK
$918.12M-21.5%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.61B+304%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$452.74M+5.3%
ALN
Alnylam PharmaceuticalsALNY
$42.43B+24.1%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$1.46B+100%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Calculated from MeiraGTx Holdings plc’s reported figures.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's enterprise value?
MeiraGTx Holdings plc (MGTX) reported enterprise value of $696.49M in Q1 2026.
How has MeiraGTx Holdings plc's enterprise value changed year-over-year?
MeiraGTx Holdings plc's enterprise value increased by 26.9% year-over-year, from $548.99M to $696.49M.
What is the long-term trend for MeiraGTx Holdings plc's enterprise value?
Over 5 years (2020 to 2025), MeiraGTx Holdings plc's enterprise value has grown at a 5.6% compound annual growth rate (CAGR), from $485.68M to $638.05M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.